Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Eledon Pharmaceuticals (ELDN) Accumulated Depreciation & Amortization (2016)

Eledon Pharmaceuticals filings provide 4 years of Accumulated Depreciation & Amortization readings, the most recent being $197000.0 for Q4 2016.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 19.39% to $197000.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $197000.0, a 19.39% increase, with the full-year FY2016 number at $197000.0, up 19.39% from a year prior.
  • Accumulated Depreciation & Amortization hit $197000.0 in Q4 2016 for Eledon Pharmaceuticals, up from $165000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $197000.0 in Q4 2016 to a low of $43000.0 in Q4 2013.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $111500.0 (2014), compared with a mean of $115750.0.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 184.48% in 2015 and later grew 19.39% in 2016.
  • Eledon Pharmaceuticals' Accumulated Depreciation & Amortization stood at $43000.0 in 2013, then surged by 34.88% to $58000.0 in 2014, then soared by 184.48% to $165000.0 in 2015, then grew by 19.39% to $197000.0 in 2016.
  • The last three reported values for Accumulated Depreciation & Amortization were $197000.0 (Q4 2016), $165000.0 (Q4 2015), and $58000.0 (Q4 2014) per Business Quant data.